Combining STING-based neoantigen-targeted vaccine with checkpoint modulators enhances antitumor immunity in murine pancreatic cancer.
Kinkead HL, Hopkins A, Lutz E, Wu AA, Yarchoan M, Cruz K, Woolman S, Vithayathil T, Glickman LH, Ndubaku CO, McWhirter SM, Dubensky TW Jr, Armstrong TD, Jaffee EM, Zaidi N.
Kinkead HL, et al.
JCI Insight. 2018 Oct 18;3(20):e122857. doi: 10.1172/jci.insight.122857.
JCI Insight. 2018.
PMID: 30333318
Free PMC article.